Logo image of MLP.CA

MILLENNIAL POTASH CORP (MLP.CA) Stock Fundamental Analysis

TSX-V:MLP - CA60041F1018 - Common Stock

2.14 CAD
-0.06 (-2.73%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

2

Overall MLP gets a fundamental rating of 2 out of 10. We evaluated MLP against 27 industry peers in the Chemicals industry. No worries on liquidiy or solvency for MLP as it has an excellent financial health rating, but there are worries on the profitability. MLP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MLP had negative earnings in the past year.
In the past year MLP has reported a negative cash flow from operations.
MLP had negative earnings in each of the past 5 years.
MLP had a negative operating cash flow in each of the past 5 years.
MLP.CA Yearly Net Income VS EBIT VS OCF VS FCFMLP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

With a Return On Assets value of -18.73%, MLP is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -21.54%, MLP is in line with its industry, outperforming 40.74% of the companies in the same industry.
Industry RankSector Rank
ROA -18.73%
ROE -21.54%
ROIC N/A
ROA(3y)-40.71%
ROA(5y)-35.79%
ROE(3y)-45.37%
ROE(5y)-97.24%
ROIC(3y)N/A
ROIC(5y)N/A
MLP.CA Yearly ROA, ROE, ROICMLP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MLP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLP.CA Yearly Profit, Operating, Gross MarginsMLP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for MLP has been increased compared to 1 year ago.
MLP has a better debt/assets ratio than last year.
MLP.CA Yearly Shares OutstandingMLP.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
MLP.CA Yearly Total Debt VS Total AssetsMLP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 48.69 indicates that MLP is not in any danger for bankruptcy at the moment.
MLP has a Altman-Z score of 48.69. This is amongst the best in the industry. MLP outperforms 96.30% of its industry peers.
MLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 48.69
ROIC/WACCN/A
WACCN/A
MLP.CA Yearly LT Debt VS Equity VS FCFMLP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

MLP has a Current Ratio of 9.58. This indicates that MLP is financially healthy and has no problem in meeting its short term obligations.
MLP has a better Current ratio (9.58) than 96.30% of its industry peers.
A Quick Ratio of 9.58 indicates that MLP has no problem at all paying its short term obligations.
MLP has a Quick ratio of 9.58. This is amongst the best in the industry. MLP outperforms 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 9.58
Quick Ratio 9.58
MLP.CA Yearly Current Assets VS Current LiabilitesMLP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MLP have decreased by -1.28% in the last year.
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MLP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLP.CA Price Earnings VS Forward Price EarningsMLP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLP.CA Per share dataMLP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MLP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MILLENNIAL POTASH CORP

TSX-V:MLP (9/4/2025, 7:00:00 PM)

2.14

-0.06 (-2.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners39.33%
Ins Owner ChangeN/A
Market Cap229.00M
Analysts84.44
Price Target2.66 (24.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)89.13%
PT rev (3m)89.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 12.05
P/tB 12.05
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.73%
ROE -21.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.71%
ROA(5y)-35.79%
ROE(3y)-45.37%
ROE(5y)-97.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3563.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.58
Quick Ratio 9.58
Altman-Z 48.69
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)693.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.84%
OCF growth 3YN/A
OCF growth 5YN/A